Sen. Charles Grassley, the ranking Republican on the Senate Finance Committee, says that the FDA’s Drug Safety Oversight Board voted 8-7 on Oct. 2 to keep the scandal-plagued diabetes drug Avandia on the market. The result was kept from the public.

Wow, what a nailbiter. That’s enough to give Glaxo execs a heart attack (or at least increase the risk of one by, oh, 43 percent.)

(Via Reuters.)

 

One Response to Avandia one vote away from elimination

  1. Dan says:

    Grassley appears to be one of our greater allies. Did you know he provides his own personal fax line on his website for potential whistleblowers?

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: